Eye tissue shortage endangers clinical research's future

July 11, 2006

Rockville, Md. − The future of clinical ophthalmology may be endangered by the decline in the number of human donor eyes provided by U.S. eye banks according to an article published in the July 2006 issue of Investigative Ophthalmology & Visual Science (IOVS).

According to a survey of U.S. members of the Association for Research in Vision and Ophthalmology (ARVO), the major prohibitory factor in the use of human eye tissue is lack of availability of tissue meeting stringent criteria. The survey's conductor, Christine A. Curcio, PhD, of ARVO's Research Tissue Acquisition Working Group (RTAWG), found that only cost exceeded this factor among those surveyed. Respondents also indicated that local eye banks are the most common tissue source although most investigators use multiple tissues sources, including remote eye banks to acquire adequate human eye tissue needed for research.

The availability of human eye tissue for research has been severely impacted by federal regulations and state laws enacted over the last decade, and some individual eye bank practices may be of importance on a local level (e.g., laws prohibiting medical examiners from releasing eye tissue in cases of violent or suspicious death).

The RTAWG believes that the decline in human research tissue may be managed in the short term by researchers working closely with eye banks and other providers, communicating on a regular basis, and clarifying their experimental needs and expectations.

"No where do impediments to obtaining human eyes for research have more impact than in the effort to understand age-related macular degeneration, the leading cause of new vision loss in the elderly," said Curcio, a professor of ophthalmology at the University of Alabama at Birmingham. "Macular degeneration, an advanced form of which now has treatment options, still lacks a laboratory animal model that displays the full range of pathology typifying the human disorder. Thus, human tissues are particularly critical."
Read this article online at http://www.iovs.org/cgi/content/full/47/7/2747.

IOVS is published by the Association for Research in Vision and Ophthalmology (ARVO). For more information, logon to www.IOVS.org.

ARVO is a membership organization of more than 11,500 eye and vision researchers from over 70 countries. Established in 1928, the Association encourages and assists its members and others in research, training, publication and dissemination of knowledge in vision and ophthalmology. ARVO's headquarters are located in Rockville, Md. For more information about ARVO, logon to www.arvo.org.

Association for Research in Vision and Ophthalmology

Related Macular Degeneration Articles from Brightsurf:

Levodopa may improve vision in patients with macular degeneration
Investigators have determined that treating patients with an advanced form of age-related macular degeneration (AMD) with levodopa, a safe and readily available drug commonly used to treat Parkinson's disease, stabilized and improved their vision.

Combating drug resistance in age-related macular degeneration
An international team of researchers led by Baylor College of Medicine and Houston Methodist has discovered a strategy that can potentially address a major challenge to the current treatment for age-related macular degeneration,

Study finds unexpected suspect in age-related macular degeneration
Scientists have identified an unexpected player in the immune reaction gone awry that causes vision loss in patients with age-related macular degeneration (AMD), according to a new study published today in eLife.

Potential way to halt blinding macular degeneration identified
It would be the first treatment for dry age-related macular degeneration and could significantly improve treatment for wet AMD.

Heating techniques could improve treatment of macular degeneration
Age-related macular degeneration is the primary cause of central vision loss and results in the center of the visual field being blurred or fully blacked out.

Eye's vulnerability to macular degeneration revealed
Scientists have found significant differences in the shape and biology of the same type of cell taken from different parts of the retina, according to a study in eLife.

Hallucinations associated with brain hyperactivity in people with macular degeneration
New research from The University of Queensland has shown for the first time that visual hallucinations in people with macular degeneration are associated with abnormally heightened activity in the visual cortex of the brain.

Eating leafy greens could help prevent macular degeneration
A new study has shown that eating vegetable nitrates, found mainly in green leafy vegetables and beetroot, could help reduce your risk of developing early-stage age-related macular degeneration (AMD).

An orange a day keeps macular degeneration away: 15-year study
A new study has shown that people who regularly eat oranges are less likely to develop macular degeneration than people who do not eat oranges.

Macular degeneration linked to aging immune cells
Studying mice and cells from patients, vision researchers at Washington University School of Medicine in St.

Read More: Macular Degeneration News and Macular Degeneration Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.